Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-05-09FDA Approved: DIHYDROERGOTAMINE MESYLATE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved a supplemental application for dihydroergotamine mesylate submitted by Oceanside Pharmaceuticals.
-
FDA approval · 2022-04-18FDA Approved: ZOLMIPTRIPTAN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's supplemental application for Zolmitriptan (ZOLMIPTRIPTAN) under ANDA 202560. This represents a supplemental appr…
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Effect of Acetyl-L-carnitine in Migraine [Phase 4]
Phase 4 trial update on acetyl-L-carnitine for migraine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Efficacy of AJOVY (Fremanezumab-vfrm) on Interictal Migraine Related Burden [Phase 4]
Phase 4 trial results evaluating the efficacy of AJOVY (fremanezumab-vfrm) on interictal migraine-related burden have been completed and res…
-
FDA approval · 2022-04-11FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for Nurtec ODT (rimegepant sulfate) from Pfizer Laboratories Div Pfizer Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-04-06FDA Approved: FROVATRIPTAN — Original Application (Ingenus Pharmaceuticals, LLC)
The FDA approved the original application for a generic frovatriptan succinate product (FROVATRIPTAN) from Ingenus Pharmaceuticals for the a…
-
FDA label_change · 2022-03-31FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Nurtec ODT (rimegepant sulfate) from Pfizer, indicating a labeling change related to this migrai…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Saline Injections for Prophylactic Treatment of Chronic Migraine [Phase 4]
A Phase 4 clinical trial evaluating saline injections as a prophylactic treatment for chronic migraine has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist [Phase 4]
Phase 4 trial update studying gastrointestinal emptying time in adults with migraine before and after starting a CGRP monoclonal antibody an…
-
FDA approval · 2022-03-04FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
The FDA approved a supplemental application for Aimovig (erenumab-aooe) by Amgen.
-
FDA approval · 2022-02-04FDA Approved: TOPIRAMATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for Topiramate from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2022-02-02FDA Approved: AMAZON BASIC CARE MIGRAINE RELIEF — Original Application (Amazon.com Services LLC)
FDA approved an original application for Amazon Basic Care Migraine Relief, a combination of acetaminophen, aspirin, and caffeine, as a gene…
-
FDA approval · 2022-01-25FDA Approved: REYVOW — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Reyvow (lasmiditan) from Eli Lilly and Company.
-
FDA approval · 2022-01-13FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Topamax (topiramate) submitted by Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children [Phase 3]
Phase 3 trial comparing intranasal ketorolac to intravenous ketorolac for treating migraine in children has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: Registry for Migraine - Structural and Functional MRI Before and After Erenumab Treatment [Phase 4]
A Phase 4 clinical trial update investigating structural and functional MRI before and after erenumab treatment for migraine/headache.
-
FDA approval · 2021-12-20FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Imitrex (sumatriptan) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2021-12-08FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA announces a supplemental application for Nurtec ODT (rimegepant sulfate) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2021-12-07FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental NDA for Excedrin Migraine GelTabs (acetaminophen, aspirin, caffeine) from Haleon US Holdings LLC.
-
CLINICAL_TRIALS withdrawal · 2021-11-26Clinical Trial Update: A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks [Phase 4]
A Phase 4 clinical trial investigating greater occipital nerve block for acute migraine attacks has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers [Phase 1]
Phase 1 crossover study assessing three intranasal formulations of M207 with zolmitriptan in healthy volunteers; completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: The MOTS (Medication Overuse Treatment Strategy) Trial [NA]
Clinical trial update for the MOTS trial on medication overuse treatment strategy in migraine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: Chordate System Prophylactic Migraine Clinical Investigation [NA]
Completed clinical trial for prophylactic migraine intervention by Chordate Medical; results posted in 2021.
-
FDA approval · 2021-11-05FDA Approved: EPRONTIA — Original Application (Azurity Pharmaceuticals, Inc.)
FDA approves EPRONTIA (topiramate) from Azurity Pharmaceuticals, Inc. via an original application for approved indications in epilepsy and m…
-
FDA approval · 2021-11-03FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application to market Excedrin Migraine Geltabs, a new dosage form of the combination product containing ace…